Cargando…
Behind a personalized therapy with immune check-point inhibitors in metastatic bladder cancer: ready for a primetime?
Autores principales: | Poletajew, Sławomir, Krajewski, Wojciech, Kryst, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807308/ https://www.ncbi.nlm.nih.gov/pubmed/33457220 http://dx.doi.org/10.21037/tau-20-907 |
Ejemplares similares
-
The Shock Index: is it ready for primetime?
por: Moffat, Brad, et al.
Publicado: (2013) -
Bladder perforation during transurethral resection of bladder tumour is not a result of a deficient structure of the bladder wall
por: Poletajew, Sławomir, et al.
Publicado: (2020) -
Commentary: Preoperative Screening CT: Not Ready for Primetime in The COVID-19 Era
por: Porterie, Jean, et al.
Publicado: (2021) -
Plk1 in Asthma: Ready for Primetime?
por: Tam, John Kit Chung, et al.
Publicado: (2021) -
eIF4A inhibition: ready for primetime?
por: Cunningham, Tyler A., et al.
Publicado: (2018)